Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
Biospace News
-
July 2, 2020
Phase II
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
Phase II
Monodar?NorthStar???????????????uPAR????????????? (RIT) ?????? Nasdaq:MNPR
Phase II
ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
Phase II
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
Phase II
Algernon to Support Planned Phase 2 Trial of Ifenprodil for Coronavirus
Biospace News
-
March 19, 2020
0
Phase II
Novo Nordisk pauses clinical trials for haemophilia drug concizumab due to...
Firstwordpharma News
-
March 17, 2020
0
Phase II
Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in...
Globenewswire News
-
March 16, 2020
0
Phase II
NuCana Reports Preliminary Data from Phase II Study of Single-Agent Acelarin...
Firstwordpharma News
-
March 10, 2020
0
Phase II
Dynacure Announces First Patient Dosed in Phase 1 / 2 ‘UNITE-CNM’...
Biospace News
-
March 5, 2020
0
1
2
3
...
32
Page 1 of 32
- Advertisement -
MOST POPULAR
Harmony Biosciences Certified As A Great Place To Work In An...
February 4, 2019
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients...
March 6, 2020
Retrophin Announces FDA Approval of THIOLA EC (tiopronin) 100mg and 300mg...
June 28, 2019
Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with...
December 2, 2019
Load more
HOT NEWS
Acquisitions
Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology...
Immuno-oncology
DeMelle OncoPharma Licenses Clinical-Stage Technology from Moffitt Cancer Center for New...
Deals
Protagonist Therapeutics Achieves Milestone in Janssen Biotech, Inc., Collaboration
Others
Report: Iovance Exploring Potential Sale of the Company
